Results 71 to 80 of about 522,058 (284)
Lifestyle Behaviors and Cardiotoxic Treatment Risks in Adult Childhood Cancer Survivors
Pediatric Blood &Cancer, EarlyView.ABSTRACT Background Higher doses of anthracyclines and heart‐relevant radiotherapy increase cardiovascular disease (CVD) risk. This study assessed CVD and CVD risk factors among adult childhood cancer survivors (CCSs) across cardiotoxic treatment risk groups and examined associations between lifestyle behaviors and treatment risks.
Ruijie Li +6 more
wiley +1 more source
Access to Medicines: the Role of Intellectual property Law and Policy [PDF]
, 2012 Intellectual property (IP) policy is an important structural determinant of health. Patent policy influences the rate and direction of innovation for health, playing a positive or negative role depending on how it is shaped and implemented.
El Said, Mohammed, Kapczynski, Amy
core
Pediatric Blood &Cancer, EarlyView.ABSTRACT We present two pediatric cases of pediatric low‐grade gliomas (PLGG) with BRAF V600E mutations diagnosed and monitored using cerebrospinal fluid (CSF) liquid biopsy analyzed via digital droplet PCR (ddPCR), without tissue biopsy. Both patients were treated with dabrafenib and trametinib and monitored through clinical assessments, magnetic ...
Hannah Sultan +5 more
wiley +1 more source
Acta Scientiarum. Health Sciences, 2012 The growing number of lawsuits to obtain free medicines from the Brazilian Health System (SUS) is analyzed to characterize the supply of the requested drugs in two towns with different social and economic characteristics and different municipal ...
Silvana Nair Leite +2 more
doaj +1 more source
Access to Medicines and the Right to (Cultural) Life [PDF]
, 2010 Published version available from: http://www.ashgate.com/isbn/9780754677611This groundbreaking book is the first collection to investigate together the law, political science and ethical perspectives on the right and value of ...
Gibson, J
core
Compulsory Licensing of Patented Pharmaceutical Inventions: Evaluating the Options [PDF]
, 2009 In this Comment, the author traces the relevant legislative history pertaining to compulsory licensing of patented pharmaceuticals from the TRIPS Agreement of 1994 to the 2003 waiver to, and later proposed amendment of, article 31, which enables poor ...
Arezzo +22 more
core +2 more sources
Pediatric Blood &Cancer, EarlyView.ABSTRACT Ongoing evidence indicates increased risk of sarcopenic obesity among children and young people (CYP) with acute lymphoblastic leukemia (ALL), often beginning early in treatment, persisting into survivorship. This review evaluates current literature on body composition in CYP with ALL during and after treatment.
Lina A. Zahed +5 more
wiley +1 more source
BMC CancerBackground Cancer is a major cause of mortality worldwide, and differences in cancer mortality rates between countries are, in part, due to differences in access to cancer care, including medicines.
Moizza Zia Ul Haq +5 more
doaj +1 more source
System and market failures: the unavailability of magnesium sulphate for the treatment of eclampsia and pre-eclampsia in Mozambique and Zimbabwe. [PDF]
, 2005 Low cost and effective drugs, such as magnesium sulphate, need to be included in initiatives to improve access to essential medicines in ...
Cliff, J +8 more
core +2 more sources
Parent‐to‐Child Information Disclosure in Pediatric Oncology
Pediatric Blood &Cancer, EarlyView.ABSTRACT Background Despite professional consensus regarding the importance of open communication with pediatric cancer patients about their disease, actual practice patterns of disclosure are understudied. Extant literature suggests a significant proportion of children are not told about their diagnosis/prognosis, which is purported to negatively ...
Rachel A. Kentor +12 more
wiley +1 more source